Ralliant (NYSE:RAL) Sets New 12-Month High – What’s Next?

Posted by George Bondi on May 28th, 2026

Shares of Ralliant Corporation (NYSE:RAL – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as $62.95 and last traded at $61.69, with a volume of 26790 shares traded. The stock had previously closed at $61.55.

Wall Street Analyst Weigh In

Several research firms have weighed in on RAL. TD Cowen boosted their price objective on Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Oppenheimer upped their price target on Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Vertical Research cut Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research report on Wednesday. Citigroup upped their price target on Ralliant from $51.00 to $70.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Finally, Morgan Stanley upped their price target on Ralliant from $45.00 to $68.00 and gave the company an “overweight” rating in a research report on Thursday, May 14th. Six investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Ralliant currently has a consensus rating of “Hold” and an average price target of $64.50.

Get Our Latest Stock Report on RAL

Ralliant Price Performance

The stock has a market cap of $6.99 billion and a P/E ratio of -5.71. The firm has a 50-day moving average price of $48.03 and a 200-day moving average price of $48.48. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61.

Ralliant (NYSE:RAL – Get Free Report) last announced its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The firm had revenue of $534.60 million during the quarter. Ralliant’s quarterly revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, analysts forecast that Ralliant Corporation will post 2.64 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.83%.

Insider Activity at Ralliant

In other news, SVP Karen M. Bick sold 2,530 shares of the firm’s stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the transaction, the senior vice president directly owned 42,652 shares in the company, valued at $1,983,318. This trade represents a 5.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Hedge Funds Weigh In On Ralliant

Institutional investors and hedge funds have recently bought and sold shares of the stock. Viking Global Investors LP bought a new stake in shares of Ralliant in the second quarter worth about $257,200,000. State Street Corp bought a new stake in Ralliant during the second quarter worth approximately $213,096,000. Millennium Management LLC increased its stake in Ralliant by 172.4% during the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after acquiring an additional 3,147,660 shares during the last quarter. Norges Bank bought a new stake in Ralliant during the fourth quarter worth approximately $124,687,000. Finally, Invesco Ltd. increased its stake in Ralliant by 90.1% during the third quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock worth $169,309,000 after acquiring an additional 1,835,128 shares during the last quarter.

About Ralliant

(Get Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.